Minocycline Dosing Per Kilogram
For moderate-to-severe inflammatory acne in patients ≥8 years, initiate minocycline at 4 mg/kg, then continue with 2 mg/kg every 12 hours, always combined with topical benzoyl peroxide and/or a retinoid. 1
Pediatric Dosing (≥8 years)
- Initial dose: 4 mg/kg 1
- Maintenance dose: 2 mg/kg every 12 hours 1
- Critical requirement: Must be combined with topical benzoyl peroxide and/or retinoid—never use as monotherapy 1
- Contraindication: Should not be used in children <8 years of age unless benefits clearly outweigh risks due to permanent tooth discoloration and enamel hypoplasia 2, 1
Adult Dosing
- Standard regimen: 50 mg once daily up to three times daily (approximately 1 mg/kg for a 50-70 kg adult) 1
- Alternative approach: The American Academy of Dermatology guidelines support the pediatric weight-based dosing of 2 mg/kg every 12 hours for adults as well 1
- Maximum daily dose: Should not exceed 200 mg/day in routine acne treatment 1
Treatment Duration and Re-evaluation
- Time-limited therapy: Re-evaluate after 3-4 months to minimize bacterial resistance 1
- Discontinuation criteria: Stop when clinical improvement is achieved 1
- Post-antibiotic maintenance: Continue topical benzoyl peroxide and/or retinoid after stopping systemic minocycline to sustain results and prevent resistance 1
Critical Safety Considerations
Absolute Contraindications
- Pregnancy (Category D): Contraindicated due to risk of embryopathy and permanent tooth discoloration 2, 1
- Breastfeeding: Drug is secreted in milk; discontinue nursing or the drug 2, 1
- Children <8 years: Contraindicated unless benefits clearly outweigh risks 2, 1
Serious Adverse Events
- Higher risk profile: 8.8 cases per 100,000 patient-years, higher than other tetracyclines 1
- Pigmentation risk: Blue-gray discoloration of skin, mucous membranes, teeth, and nails, especially with cumulative doses >70 g 1
- Rare but severe reactions: Hepatotoxicity (including fatal hepatic failure), agranulocytosis, hemolytic anemia, myocarditis, pericarditis, pneumonitis 2, 1
- Pseudotumor cerebri: Benign intracranial hypertension can occur; severe headache requires immediate evaluation 2, 1
Drug Interactions Requiring Dose Separation or Avoidance
- Antacids (aluminum, calcium, magnesium): Separate by 2-3 hours to avoid decreased absorption 2, 1
- Isotretinoin: Avoid concurrent use due to increased risk of pseudotumor cerebri 2, 1
- Hormonal contraceptives: May reduce efficacy; advise backup contraception 2, 1
- Oral anticoagulants: May potentiate anticoagulant effect; monitor coagulation parameters 2, 1
- Methoxyflurane: Heightens nephrotoxicity risk; avoid co-administration 2, 1
Common Pitfalls to Avoid
- Monotherapy error: Never prescribe minocycline alone for acne—this accelerates bacterial resistance and violates guideline recommendations 1
- Indefinite use: Minocycline is not intended for long-term maintenance; limit to 3-4 months 1
- Inadequate contraception counseling: Always verify reliable contraception in women of childbearing potential before initiating therapy 1
- Ignoring vestibular symptoms: Dizziness, vertigo, or tinnitus warrant immediate evaluation and possible discontinuation 1